دورية أكاديمية

The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis

التفاصيل البيبلوغرافية
العنوان: The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis
المؤلفون: Lima, Svetlana F., Pires, Silvia, Rupert, Amanda, Oguntunmibi, Seun, Jin, Wen-Bing, Marderstein, Andrew, Funez-dePagnier, Gabriela, Maldarelli, Grace, Viladomiu, Monica, Putzel, Gregory, Yang, Wei, Tran, Nancy, Xiang, Grace, Grier, Alex, Guo, Chun-Jun, Lukin, Dana, Mandl, Lisa A., Scherl, Ellen J., Longman, Randy S.
المساهمون: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
المصدر: Cell Reports Medicine ; volume 5, issue 3, page 101431 ; ISSN 2666-3791
بيانات النشر: Elsevier BV
سنة النشر: 2024
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.xcrm.2024.101431
الإتاحة: https://doi.org/10.1016/j.xcrm.2024.101431Test
https://api.elsevier.com/content/article/PII:S2666379124000545?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666379124000545?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://www.elsevier.com/legal/tdmrep-licenseTest ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.759F5F6B
قاعدة البيانات: BASE